Andrew Ross Sorkin Is DEAD WRONG About Ackman’s JC Penney Loss

Michael J. De La Merced and Andrew Ross Sorkin wrote an article about Dan Loeb and Bill Ackman yesterday. Andrew Ross Sorkin is pretty close to Ackman and talked to him about his JC Penney (NYSE:JCP) investment extensively on CNBC. However, we have a feeling that he doesn’t like Ackman that much because he wasn’t very nice to Bill Ackman a couple of months ago on CNBC . Another reason that makes us think ARS doesn’t like Ackman is this sentence from yesterday’s Dealbook article:

He is also bullish on a turnaround at J. C. Penney, bringing in the former Apple retail chief Ron Johnson. But since his first investment in late 2010, Penney’s stock has fallen 31 percent.

This is  DEAD WRONG.

Bill Ackman PERSHING SQUARE

The truth is that Ackman’s loss from his “first investment in late 2010″ is 8%, not 31% as Andrew Ross Sorkin claims.

Here’s why we know ARS is wrong…

In the article Andrew Ross Sorkin implies Ackman first bought JCP at around $27.50.  According to this Deal Journal article dated October 11, 2010,

From Aug. 17 through Aug. 26, Pershing Square accumulated just under 11.6 million shares of Penney at an average cost of about $20.63 apiece, putting Mr. Ackman just below the 5% threshold requiring stake disclosure. There Mr. Ackman waited, undetected, for more than a month while evaluating his target and contemplating the next move.

Then, on Sept. 28, the hedge fund negotiated an over-the-counter “call” option with a counterparty that allowed it to buy four million shares, between then and Dec. 27, at just $12.24 apiece. That took his potential ownership to federal filing territory.

Pershing Square paid $12.86 apiece for these options, and because it exercised them early it pocketed a fee that lowered the average exercise price to $12.04 apiece, making its total purchase price for those four million shares $24.90 apiece.

Mr. Ackman then, operating in secrecy under the 10-day window investors are given to file the initial ownership documents, went on a buying binge.

All told, Pershing Square paid about $903 million for its entire Penney position, and just its common stock alone is already worth more than $1.14 billion following Friday’s run-up on the news.

PERSHING SQUARE Bill AckmanAs you can see the average cost of Ackman’s first investment in JCP was less than $21. On September 28th 2010 he acquired 4 million more shares at an average cost of $24.90. Between September 29th and October 4th, JCP’s market price ranged between $26 and $27.63. So Ackman’s average price around this time couldn’t have been more than $27 per share. See where we’re going? It’s mathematically very difficult to have an average price of $27.50 after acquiring nearly a third of your position below $21 and the stock traded above $27.63 in only 4 trading days before Ackman disclosed his stake.

Ackman spent $903 million for the entire JCP position and what did he get in return? According to his 2010Q4 13-F filing, Ackman had 34.9 million common shares and 4.2 million call options. This CNN Money writer assumed that call options are identical to common shares and calculated an average price of around $23 for Ackman’s gigantic position in JCP. This is a wrong estimate too (on the low side). However, even if we assume that Ackman’s 4.2 million share call option position is worthless, the average cost of Ackman’s JCP position COULD NOT be more than $25.86.

In case you don’t know math well enough to understand our calculations, consider this – last October at the Value Investing Conference Bill Ackman stated that his average cost of the JCP position is $25 per share (however this estimate probably includes later purchases by Ackman – some of which were made when the stock was trading as high as $38 a piece).

Andrew Ross Sorkin is clearly wrong about Ackman’s loss in J.C. Penney. Ackman’s initial cost was less than $21. The average cost for Ackman’s entire position is probably less than $25 and that’s only because he decided to triple his initial investment. Ackman’s loss from his initial position is 8%, not 31% as Andrew Ross Sorkin claims. Ackman’s loss from his entire position is 24%, still less than the 31% “estimated” by Andrew Ross Sorkin.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!